Skip to the guide
Follow-up desk · Before your visit

Make a plan for questions after the visit.

Before leaving, ask who will answer you, what changes to watch for, and where to get help. Put the answers beside the medicine’s exact name.

U.S. care context: September 2026.

A clear route back

Who answers the next question?

Ask for the reply process in words you can use later. Keep the details with your visit notes.

The instructions you receive

Ask for an explanation you can repeat back

The Food and Drug Administration (FDA), the U.S. medicine review agency, keeps reports of medicine problems.

Reports held by FDA in September 2026 include hospital stays following possible mistakes in measuring or calculating the injection amount for made-to-order semaglutide.

Some patients measured the amount incorrectly; some health professionals calculated it incorrectly.

Storage and delivery

Ask about this product’s storage needs

The product determines storage instructions in September 2026: cold storage is needed for some peptide medicines but not for others.

FDA advises against using a weight medicine given as a shot if it arrives warm or without enough refrigeration.

If pregnancy could apply to you

Ask about pregnancy or breastfeeding

Use these questions if you are pregnant, breastfeeding, or planning a pregnancy. Otherwise, continue to the urgent-help section below.

The official medicine instructions give different pregnancy advice for semaglutide (Ozempic) and tirzepatide (Zepbound), as checked in September 2026.

Urgent help

Severe allergy symptoms need emergency care

MedlinePlus guidance, checked in September 2026, calls for emergency care when an allergic reaction is severe.

Get emergency care if symptoms are severe, including breathing trouble or swelling of the tongue.

Read with a purpose

A short reading list